Breaking the Bond Between Cravings and Consumption
A researcher from New Zealand reveals the importance of the lateral septum in breaking the bond between cravings and consumption.
85% Reduction in Substance Use Disorders With GLP-1 Drugs
A new study finds stunning declines in substance use disorders when people with obesity or type 2 diabetes use GLP-1 drugs.
How Ozempic Changes the Brain
New research shows GLP-1 drugs such as Ozempic improve connectivity in brain regions associated with managing stress.
Food Noise, Set Points, and GLP-1 Drugs
The New York Times tries to find out how GLP-1 drugs quiet food noise.
Do GLP-1 Drugs Cause Six-Seven Syndrome?
In curbing the cravings for dopamine surges, GLP-1 drugs appear to be dulling the appetite for everyday pleasures.
GLP-1 Pills are the “Next Phase” in the Weight-Loss Drug Era
Eli Lilly wins approval for Foundayo, a new GLP-1 drug in pill form, but will it outperform Novo Nordisk’s Wegovy pill?